Literature DB >> 19775865

Predictors of social anxiety in an opioid dependent sample and a control sample.

Fiona L Shand1, Louisa Degenhardt, Elliot C Nelson, Richard P Mattick.   

Abstract

Compared to other mental health problems, social anxiety is under-acknowledged amongst opioid dependent populations. This study aimed to assess levels of social anxiety and identify its predictors in an opioid dependent sample and a matched control group. Opioid dependent participants (n=1385) and controls (n=417) completed the Social Interaction Anxiety Scale (SIAS), the Social Phobia Scale (SPS) and a diagnostic interview. Regression analyses were used to test a range of predictors of social anxiety. Opioid dependent cases had higher mean scores on both scales compared to controls. Predictors of social anxiety centred on emotional rejection in childhood, either by parents or peers. For opioid dependent cases, but not controls, lifetime non-opioid substance dependence (cannabis, sedatives, and tobacco) was associated with higher levels of social anxiety. However, much of the variance in social anxiety remains unexplained for this population.

Entities:  

Mesh:

Year:  2010        PMID: 19775865      PMCID: PMC3001130          DOI: 10.1016/j.janxdis.2009.08.010

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  44 in total

1.  Initial drug abuse: a review of predisposing social psychological factors.

Authors:  R L Gorsuch; M C Butler
Journal:  Psychol Bull       Date:  1976-01       Impact factor: 17.737

Review 2.  The etiology of social phobia: empirical evidence and an initial model.

Authors:  Ronald M Rapee; Susan H Spence
Journal:  Clin Psychol Rev       Date:  2004-11

3.  Risk factors for drug use among adolescents: concurrent and longitudinal analyses.

Authors:  M D Newcomb; E Maddahian; P M Bentler
Journal:  Am J Public Health       Date:  1986-05       Impact factor: 9.308

Review 4.  The Christchurch Child Development Study: a review of epidemiological findings.

Authors:  D M Fergusson; L J Horwood; F T Shannon; J M Lawton
Journal:  Paediatr Perinat Epidemiol       Date:  1989-07       Impact factor: 3.980

5.  Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study.

Authors:  Ron de Graaf; Rob V Bijl; Filip Smit; Wilma A M Vollebergh; J Spijker
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

6.  Christchurch Psychiatric Epidemiology Study, Part I: Methodology and lifetime prevalence for specific psychiatric disorders.

Authors:  J E Wells; J A Bushnell; A R Hornblow; P R Joyce; M A Oakley-Browne
Journal:  Aust N Z J Psychiatry       Date:  1989-09       Impact factor: 5.744

7.  Enhanced Stroop interference for threat in social phobia.

Authors:  Nader Ami; Melinda Freshman; Edna Foa
Journal:  J Anxiety Disord       Date:  2002

8.  Family transmission and heritability of externalizing disorders: a twin-family study.

Authors:  Brian M Hicks; Robert F Krueger; William G Iacono; Matt McGue; Christopher J Patrick
Journal:  Arch Gen Psychiatry       Date:  2004-09

9.  Association between anxiety disorders and substance use disorders among young persons: results of a 21-year longitudinal study.

Authors:  Renee D Goodwin; David M Fergusson; L John Horwood
Journal:  J Psychiatr Res       Date:  2004 May-Jun       Impact factor: 4.791

Review 10.  The etiology of social phobia: toward a developmental profile.

Authors:  Jo Anne Neal; Robert J Edelmann
Journal:  Clin Psychol Rev       Date:  2003-11
View more
  11 in total

1.  Genome-wide meta-analysis identifies a novel susceptibility signal at CACNA2D3 for nicotine dependence.

Authors:  Xianyong Yin; Chris Bizon; Jeffrey Tilson; Yuan Lin; Ian R Gizer; Cindy L Ehlers; Kirk C Wilhelmsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-04-25       Impact factor: 3.568

2.  Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression.

Authors:  Arpana Agrawal; Elliot C Nelson; Andrew K Littlefield; Kathleen K Bucholz; Louisa Degenhardt; Anjali K Henders; Pamela A F Madden; Nicholas G Martin; Grant W Montgomery; Michele L Pergadia; Kenneth J Sher; Andrew C Heath; Michael T Lynskey
Journal:  Arch Gen Psychiatry       Date:  2012-07

3.  Association of OPRD1 polymorphisms with heroin dependence in a large case-control series.

Authors:  Elliot C Nelson; Michael T Lynskey; Andrew C Heath; Naomi Wray; Arpana Agrawal; Fiona L Shand; Anjali K Henders; Leanne Wallace; Alexandre A Todorov; Andrew J Schrage; Pamela A F Madden; Louisa Degenhardt; Nicholas G Martin; Grant W Montgomery
Journal:  Addict Biol       Date:  2012-04-13       Impact factor: 4.280

4.  Divergent behavioral responses in protracted opioid withdrawal in male and female C57BL/6J mice.

Authors:  Isabel M Bravo; Brennon R Luster; Meghan E Flanigan; Patric J Perez; Elizabeth S Cogan; Karl T Schmidt; Zoe A McElligott
Journal:  Eur J Neurosci       Date:  2019-10-06       Impact factor: 3.386

5.  ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure.

Authors:  Elliot C Nelson; Michael T Lynskey; Andrew C Heath; Naomi Wray; Arpana Agrawal; Fiona L Shand; Anjali K Henders; Leanne Wallace; Alexandre A Todorov; Andrew J Schrage; Nancy L Saccone; Pamela A F Madden; Louisa Degenhardt; Nicholas G Martin; Grant W Montgomery
Journal:  JAMA Psychiatry       Date:  2013-03       Impact factor: 21.596

6.  PTSD risk associated with a functional DRD2 polymorphism in heroin-dependent cases and controls is limited to amphetamine-dependent individuals.

Authors:  Elliot C Nelson; Andrew C Heath; Michael T Lynskey; Arpana Agrawal; Anjali K Henders; Lisa M Bowdler; Alexandre A Todorov; Pamela A F Madden; Elizabeth Moore; Louisa Degenhardt; Nicholas G Martin; Grant W Montgomery
Journal:  Addict Biol       Date:  2013-05-06       Impact factor: 4.280

7.  Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis.

Authors:  Thomas Santo; Gabrielle Campbell; Natasa Gisev; Lucy Thi Tran; Samantha Colledge; Gian Luca Di Tanna; Louisa Degenhardt
Journal:  Drug Alcohol Depend       Date:  2020-12-20       Impact factor: 4.492

8.  The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Psychiatry       Date:  2018-11-01       Impact factor: 27.083

9.  HIV-1 Tat and morphine decrease murine inter-male social interactions and associated oxytocin levels in the prefrontal cortex, amygdala, and hypothalamic paraventricular nucleus.

Authors:  Sara R Nass; Arianna R S Lark; Yun K Hahn; Virginia D McLane; Therese M Ihrig; Liangru Contois; T Celeste Napier; Pamela E Knapp; Kurt F Hauser
Journal:  Horm Behav       Date:  2021-06-23       Impact factor: 3.492

10.  Single cell transcriptomics reveals opioid usage evokes widespread suppression of antiviral gene program.

Authors:  Tanya T Karagiannis; John P Cleary; Busra Gok; Andrew J Henderson; Nicholas G Martin; Masanao Yajima; Elliot C Nelson; Christine S Cheng
Journal:  Nat Commun       Date:  2020-05-26       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.